Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3966583
Max Phase: Preclinical
Molecular Formula: C12H15NO4S2
Molecular Weight: 301.39
Molecule Type: Small molecule
Associated Items:
ID: ALA3966583
Max Phase: Preclinical
Molecular Formula: C12H15NO4S2
Molecular Weight: 301.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(Cc1ccccc1)C1=CS(=O)(=O)CCS1(=O)=O
Standard InChI: InChI=1S/C12H15NO4S2/c13-11(8-10-4-2-1-3-5-10)12-9-18(14,15)6-7-19(12,16)17/h1-5,9,11H,6-8,13H2
Standard InChI Key: DZZLWUIPTILNOX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 301.39 | Molecular Weight (Monoisotopic): 301.0442 | AlogP: 0.24 | #Rotatable Bonds: 3 |
Polar Surface Area: 94.30 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 6.77 | CX LogP: -0.89 | CX LogD: -0.98 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.86 | Np Likeness Score: -0.38 |
1. (2002) 1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor, |
Source(1):